Abhijit V Kshirsagar
Overview
Explore the profile of Abhijit V Kshirsagar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
133
Citations
2056
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Song M, Plantinga L, Metzger M, Noorani N, Lea J, Kshirsagar A, et al.
Am J Kidney Dis
. 2025 Jan;
PMID: 39863263
Rationale & Objective: Sharing Patient's Illness Representations to Increase Trust (SPIRIT) is an evidence-based advance care planning intervention targeting dialysis patients and their surrogate decision-makers. To address SPIRIT's implementation potential,...
2.
Xi Y, Wettstein Z, Kshirsagar A, Liu Y, Zhang D, Hang Y, et al.
Kidney Int Rep
. 2024 Oct;
9(10):2946-2955.
PMID: 39430197
Introduction: In many parts of the world, ambient temperatures have increased due to climate change. Due to loss of renal function, which impacts the regulation of thermoregulatory mechanisms, the ability...
3.
Troost J, DSouza J, Buxton M, Kshirsagar A, Engel L, OLenick C, et al.
Kidney Int Rep
. 2024 Aug;
9(8):2527-2536.
PMID: 39156153
Introduction: Environmental contributors to kidney disease progression remain elusive. We explored how residential air pollution affects disease progression in patients with primary glomerulopathies. Methods: Nephrotic Syndrome Study Network (NEPTUNE) and...
4.
Saha M, Hogan S, Falk R, Barnes E, Hu Y, Kshirsagar A, et al.
Kidney Med
. 2024 Jul;
6(7):100836.
PMID: 38947772
Rationale & Objective: About 25%-40% of patients with inflammatory bowel disease (IBD) may have extraintestinal manifestations, mainly involving the liver, skin, and joints. Kidney involvement in patients with IBD has...
5.
Jain G, Kshirsagar A
Kidney Int Rep
. 2024 Jun;
9(6):1565-1567.
PMID: 38899212
No abstract available.
6.
Dillon D, Ward-Caviness C, Kshirsagar A, Moyer J, Schwartz J, Di Q, et al.
Environ Health
. 2024 Apr;
23(1):43.
PMID: 38654228
Background: Chronic kidney disease (CKD) affects more than 38 million people in the United States, predominantly those over 65 years of age. While CKD etiology is complex, recent research suggests...
7.
Song M, Manatunga A, Plantinga L, Metzger M, Kshirsagar A, Lea J, et al.
JAMA Netw Open
. 2024 Jan;
7(1):e2351511.
PMID: 38289604
Importance: Evidence of effectiveness of advance care planning (ACP) strategies for patients receiving dialysis and their families is needed. Objectives: To test the effectiveness of an ACP intervention to prepare...
8.
Virkud A, Chang P, Funk M, Kshirsagar A, Edwards J, Pate V, et al.
Am J Cardiol
. 2023 Nov;
210:208-216.
PMID: 37972425
Loop diuretics are a standard pharmacologic therapy in heart failure (HF) management. Although furosemide is most frequently used, torsemide and bumetanide are increasingly prescribed in clinical practice, possibly because of...
9.
Xi Y, Richardson D, Kshirsagar A, Flythe J, Whitsel E, Wade T, et al.
Kidney360
. 2023 Jan;
4(1):63-68.
PMID: 36700905
Background: Ambient particles with a median aerodynamic diameter of <2.5 µm (PM2.5) is a ubiquitous air pollutant with established adverse health consequences. While postulated to promote a systemic inflammatory response,...
10.
Kshirsagar A, Zeitler E, Weaver A, Franceschini N, Engel L
Kidney360
. 2023 Jan;
3(12):2174-2182.
PMID: 36591345
Accumulating evidence underscores the large role played by the environment in the health of communities and individuals. We review the currently known contribution of environmental exposures and pollutants on kidney...